Total Funding
39
66
Total FundingSeries A raised
Growth Score
0 pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
77637
Corisma develops a catheter implanted circulatory assist device designed to treat patients suffering from advanced heart failure.
- Colin M. Rolph: Chief Financial Officer
- Mike Theran: CEO and FounderPast Role: CardioPhotonics, Vice President Research and Development, Founder
About the Company
Spun out of the Bonde Artificial Heart Lab at Yale University, Bonde Innovations is developing an innovative, catheter implanted circulatory assist device, CoRISMA, to treat Class 3 and Class 4 heart failure patients. With $2M+ grant funding, CoRISMA has been designed to improve patients' quality of life and reduce cost and invasiveness
associated with the current therapies. All the components of the devices have been prototyped and tested at Yale.
